Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Serum transforming growth factor-beta (TGF-beta) exhibits biological latency.
• The molecular mechanisms underlying TGF-beta latency in serum were not fully understood.

Purpose of the Study:

• To identify the specific serum binding protein responsible for TGF-beta latency.
• To elucidate the nature of the interaction between TGF-beta and its binding protein.

Main Methods:

• Affinity labeling of the TGF-beta binding protein with 125I-TGF-beta.
• Sodium dodecyl sulfate-gel electrophoresis and gel filtration chromatography for Mr and subunit determination.
• Immunoprecipitation using anti-alpha 2-macroglobulin (alpha 2M) antibodies.
• Immunoblot analysis and fast protein liquid chromatography (FPLC).

Main Results:

• The TGF-beta binding protein was identified as alpha 2-macroglobulin (alpha 2M).
• Both added and endogenous serum TGF-beta bind to alpha 2M.
• Endogenous TGF-beta forms covalent bonds with alpha 2M, unlike added TGF-beta.
• The interaction between TGF-beta and alpha 2M was confirmed to cause serum TGF-beta latency.

Conclusions:

• Alpha 2-macroglobulin is the primary binding protein responsible for latent transforming growth factor-beta in serum.
• Alpha 2M may play a crucial role in inflammatory sites by sequestering active peptides and proteases.
• Understanding this interaction provides insight into TGF-beta regulation and potential therapeutic targets.